通过可穿戴技术改善帕金森病的管理:一个成本效益的角度
Daniel Rodriguez-Martin1, Andreu Català2, Joan Cabestany2
1Sense4Care S.L., Cornellà de Llobregat, Spain.
PloS one
|October 10, 2025
概括
像STAT-ONTM这样的可穿戴传感器可以降低帕金森病的医疗费用.
科学领域:
- 神经科学与健康经济学
- 医疗技术评估 医疗技术评估
背景情况:
- 帕金森病 (PD) 影响全球数百万人,带来了重大的经济和社会挑战.
- 随着医疗保健成本的上升,需要具有成本效益的患者管理解决方案.
- 可穿戴医疗设备为增强PD症状监测和治疗优化提供了潜力.
研究的目的:
- 对将STAT-ONTM可穿戴设备集成到欧洲医疗保健系统中进行成本效益分析.
- 评估持续监测对帕金森病早期症状检测的经济影响.
- 评估STAT-ONTM在降低PD患者整体医疗保健支出方面的潜力.
主要方法:
- 成本效益分析将STAT-ONTM整合到西班牙,瑞典,德国,意大利和英国的医疗保健系统中.
- 利用验证的临床数据,通过持续监测评估早期症状检测对经济的影响.
- 根据优化药物治疗方案和减少住院治疗,估计潜在的成本降低.
主要成果:
- 通过STAT-ONTM改善症状评估,可以使药物得到优化,减少住院和机构护理费用.
- 虽然药物费用可能会上,但整体直接医疗保健费用会下降,从而产生净储蓄.
- 估计潜在的成本削减在德国高达1378万欧元,在瑞典高达1900万欧元.
结论:
- STAT-ONTM 显示出其作为一种有价值的工具的潜力,可以降低医疗保健成本并改善帕金森病管理中的患者结果.
- 该研究支持在临床实践中采用可穿戴监测设备进行客观的PD评估.
- 建议进行进一步的纵向研究,以验证在各种医疗保健环境中长期的经济和临床益处.
相关概念视频
Parkinson's Disease: Treatment
983
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K


